| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/10/1996 | EP0448697B1 Vitamin a analogues and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same |
| 04/10/1996 | EP0352295B2 Biodadhesion drug carriers for endothelial and epithelial uptake and lesional localization of therapeutic and diagnostic agents |
| 04/10/1996 | CN1120339A New prednisolone derivates |
| 04/10/1996 | CN1120338A Unsaturated phosphonates derivatives of purines and pyrimidines |
| 04/10/1996 | CN1120337A Process for production of an imidazole derivative |
| 04/10/1996 | CN1120336A Imidazoloquinoxalinone derivatives as eaa antagonists |
| 04/10/1996 | CN1120334A Heterocyclic derivatives as platelet aggregation inhibitors |
| 04/10/1996 | CN1120316A HIV protease inhibitors in pharmaceutical combinations for the treatment of AIDS |
| 04/10/1996 | CN1120314A Method and composition for treatment of osteoporosis |
| 04/10/1996 | CN1120313A Heart failure remedy |
| 04/10/1996 | CN1120312A Retarded-action microtablet made of beta-phenylpropiophenone derivatives |
| 04/10/1996 | CN1120311A Pharmaceutical composition containing lipophilic drugs |
| 04/10/1996 | CN1120304A Method and composition for treatment of osteoporosis |
| 04/10/1996 | CN1120046A Lobaplatin-Trihydrat |
| 04/10/1996 | CN1120045A New cephalosporins containing in position 7 a substituted benzyloxyimino radical, their preparation process, their use as medicaments |
| 04/10/1996 | CN1120044A Preparation of N-9 substituted guanine compounds |
| 04/10/1996 | CN1120042A Substituted 1-(7-chloroquinolin-4-yl)pyrazole-3-carboxamide N-oxide derivatives, method of preparing them and the pharmaceutical compositions in which they are present |
| 04/10/1996 | CN1120041A Novel benzobiulkyl, preparation of same and parmaceutical composition of same |
| 04/10/1996 | CN1120040A Identification and use of protease inhibitors |
| 04/10/1996 | CN1120039A Acylated aminoalknimidazoles and-triazoles |
| 04/10/1996 | CN1120038A Substituted ester of piperidine-1-alcohol, preparation and pharmaceutical use of same |
| 04/10/1996 | CN1120036A N-substituting group-4-substituted benzyl-5-alkyl-5-substituted benzyl-pyrrolidone-2, and its intermediate, its synthetic method and its appliance |
| 04/10/1996 | CN1119940A Combination treatment for inhibiting bone loss |
| 04/09/1996 | US5506356 N-acylamino acid derivatives and their use |
| 04/09/1996 | US5506355 Method for preparing cyclic sulfamides and their use for the synthesis of HIV protease inhibitors |
| 04/09/1996 | US5506347 Lyxofuranosyl analogues of adenosine |
| 04/09/1996 | US5506339 Octapeptide analogs of somatostatin having threonine at the sixth position |
| 04/09/1996 | US5506334 Salts of pyromellitic acid, a process for their preparation and their use |
| 04/09/1996 | US5506270 Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women |
| 04/09/1996 | US5506269 Parasiticide employing pyrethroid type compounds |
| 04/09/1996 | US5506268 Use of isovaleramide as a mild anxiolytic and sedative agent |
| 04/09/1996 | US5506266 Controls free radical induced damage arising from myocardial infraction or stroke, perticularyl heart damage |
| 04/09/1996 | US5506265 Prostacyclin and carbacyclin derivatives as agents for the treatment of multiple sclerosis |
| 04/09/1996 | US5506264 Antiulcer, antiinflammatory agents; reacting tranexamic acid with zinc compound and alkali agent |
| 04/09/1996 | US5506258 Exhibit affinity for the biological receptors of neuropeptides y, which are present in the central and peripheral nervous systems |
| 04/09/1996 | US5506249 Antiinflammatory, antiproliferative and antitumor activity |
| 04/09/1996 | US5506248 Salt of ifetroban and one or more basifying agents |
| 04/09/1996 | US5506243 Sulfonamide derivatives |
| 04/09/1996 | US5506242 Arylsufonamido-substituted hydroxamic acids |
| 04/09/1996 | US5506241 Inhibits fibrin formation in anterior chamber |
| 04/09/1996 | US5506240 Hypotensive agents |
| 04/09/1996 | US5506237 Bicyclic nitrogen compounds |
| 04/09/1996 | US5506235 Quinoline derivatives as immunostimulants |
| 04/09/1996 | US5506234 Psychopharmaceutical agents which bind to benzodiazepine receptors; anxiolytic agents; minimal side effects |
| 04/09/1996 | US5506233 Desosamino derivatives of macrolides as immunosuppressants and antifungal agents |
| 04/09/1996 | US5506232 High purity antitumor agents with reduced side effects |
| 04/09/1996 | US5506231 Administering an antagonist of excitatory amino acids to reduce central nervous system disorder caused by human immunodeficiency virus infection |
| 04/09/1996 | US5506230 Oil in water emulsion consists of 2,3-dihydro-1h indene cmpound, an oil, phospholipid as an emulsifier, glycerol as an isotonic agent and water; useful for improving anoxemic and hypoxic syndromes, prevents arrythemia and heart failure |
| 04/09/1996 | US5506229 Skeletal and muscle disorders |
| 04/09/1996 | US5506228 2,6-diaryl pyridazinones with immunosuppressant activity |
| 04/09/1996 | US5506227 Pyridine-substituted benzyl alcohols as leukotriene antagonists |
| 04/09/1996 | US5506226 Topical application; controlling intraocular pressure |
| 04/09/1996 | US5506225 Antibacterial penem compounds |
| 04/09/1996 | US5506224 N-acyl derivatives of aminoalcohols active as local autacoids and useful in the therapy of autoimmune processes |
| 04/09/1996 | US5506223 Δ5-androstenes useful for promoting weight maintenance or weight loss and treatment process |
| 04/09/1996 | US5506222 Method and composition for treating increased androgenic activity |
| 04/09/1996 | US5506221 Contignasterol, and related 3-alpha hydroxy-6-alpha hydroxy-7-beta hydroxy-15-keto-14-beta steroids useful as anti-inflammatory and anti-thrombosis agents |
| 04/09/1996 | US5506220 Derivatives of 17-alpha-hydroxy-3,20-dioxo-19-norpregna-4-ene |
| 04/09/1996 | US5506218 Intravenously administering a protein and peptide free phospholipid and neutral lipid to the subject; prophylaxis |
| 04/09/1996 | US5506214 Use of substituted adenine derivatives for treating multiple sclerosis |
| 04/09/1996 | US5506213 Adminstration of 2'-halo-2'-deoxy adenosine to treat inflammatory bowel disease |
| 04/09/1996 | US5506211 Soybean extract; bone disorders, cancer |
| 04/09/1996 | US5506210 Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs |
| 04/09/1996 | US5505963 Slow release pharmaceutical preparation |
| 04/09/1996 | US5505961 Increasing solubility |
| 04/09/1996 | US5505960 Liposomal piroxicam formulations |
| 04/09/1996 | US5505959 Pharmaceutical composition in gel form in a dispensing package |
| 04/09/1996 | US5505954 Also containing carboxypolymethylene, edta; preventing secondary hemorrhage |
| 04/09/1996 | US5505949 Mixture of clortrimazole, betamethasone and salicylic acid |
| 04/09/1996 | US5505784 Polycondensates which contain tartaric acid derivatives, processes for their preparation and use thereof |
| 04/09/1996 | US5505715 Iontophoretic transdermal delivery of deoxyspergualin compounds |
| 04/09/1996 | CA1338238C Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids |
| 04/08/1996 | CA2160092A1 Antihypertriglyceridemic composition |
| 04/08/1996 | CA2159938A1 Oxime derivatives, their preparation and their therapeutic use |
| 04/07/1996 | CA2159957A1 Regulated genes by stimulation of chondrocytes with il-1.beta. |
| 04/06/1996 | CA2159772A1 5-ht1f agonists for the treatment of migraine |
| 04/06/1996 | CA2159767A1 5-ht1f mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine |
| 04/05/1996 | CA2159547A1 Quinolone- and naphthyridonecarboxylic acid derivatives |
| 04/04/1996 | WO1996010042A1 Method of producing starch decomposition products |
| 04/04/1996 | WO1996010035A1 Inhibitors of farnesyl-protein transferase |
| 04/04/1996 | WO1996010034A2 Thiol-free inhibitors of farnesyl-protein transferase |
| 04/04/1996 | WO1996010033A1 Sterol compositions from pulping soap |
| 04/04/1996 | WO1996010031A1 Novel androstanes for inducing hypothalamic effects |
| 04/04/1996 | WO1996010028A1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE |
| 04/04/1996 | WO1996010027A1 N-substituted piperidinyl bicyclic benzoate derivatives |
| 04/04/1996 | WO1996010023A1 1,2,3,4-tetrahydroquinoxalindione derivative |
| 04/04/1996 | WO1996010022A1 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents |
| 04/04/1996 | WO1996010019A1 Imidazole derivative |
| 04/04/1996 | WO1996010018A1 Certain aminomethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands |
| 04/04/1996 | WO1996010015A1 Cryptolepine analogs with hypoglycemic activity |
| 04/04/1996 | WO1996010013A1 Five membered heterocyclic compounds |
| 04/04/1996 | WO1996010012A1 Novel prostaglandin synthase inhibitors |
| 04/04/1996 | WO1996010003A1 Processes for the preparation of (e)-2-fluoromethylene-4-(4-fluorophenyl) butylamine and alkali metal salts of diformylamide |
| 04/04/1996 | WO1996009835A1 Novel mitogen activated protein kinase, frk |
| 04/04/1996 | WO1996009831A2 Compositions containing at least one glucocorticoid in combination with a pulmonary surfactant for the treatment of irds and ards |
| 04/04/1996 | WO1996009828A1 Highly sulfated maltooligosaccharides with heparin-like properties |
| 04/04/1996 | WO1996009827A2 Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor |
| 04/04/1996 | WO1996009826A2 Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy |
| 04/04/1996 | WO1996009825A1 Prostagladin analogues by the oral or vaginal route for the routine management of the third stage of labour |
| 04/04/1996 | WO1996009824A1 Method for improving reproductive efficiency in farm animals |